Join
Live feed
·
INSIDERFilingvia Quantisnow
Neoleukin Therapeutics Inc. logo

SEC Form 4: Smith Sean Michael converted options into 12,500 shares and sold $1,980 worth of shares (3,316 units at $0.60), increasing direct ownership by 136% to 15,960 units to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
NLTX· Neoleukin Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NLTX (Neoleukin Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Smith Sean Michael converted options into 12,500 shares and sold $1,980 worth of shares (3,316 units at $0.60), increasing direct ownership by 136% to 15,960 units to cover taxes | Quantisnow